Clinical trial
Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
NCT05640024 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR Inhibitors
- Lead sponsor
- Yonsei University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 6, 2022
- Completion date
- October 30, 2025
- Enrollment
- 54 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer